BELGIUM THERAPY: what changed
BELGIUM THERAPY
Largest movements
- Cash +€3,247
up €3,247 (+119%), from €2,736 to €5,984
mainly Depreciation (+€3,922) and Trade debts (+€2,177)
- Receivables within one year -€2,116
down €2,116 (-44.2%), from €4,786 to €2,670
- Trade debts +€2,177
up €2,177 (+91.8%), from €2,370 to €4,547
- Tax, wage and social debts -€938
down €938 (-41.4%), from €2,264 to €1,325
- Profit (loss) carried forward -€892
down €892 (-172%), from -€518 to -€1,410
- Other debts +€612
up €612 (+3.9%), from €15,660 to €16,272
- Depreciation +€1,425
up €1,425 (+57.1%), from €2,496 to €3,922
- Gross operating margin +€696
up €696 (+28.9%), from €2,408 to €3,105
- Other operating charges -€395
no longer reported in 2025 (was €395)
- Financial charges +€39
up €39 (+112%), from €35 to €74
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €21,776 | €22,735 | +€959 | +4.4% |
| Fixed assets | 21/28 | €14,254 | €14,082 | -€172 | -1.2% |
| Tangible fixed assets | 22/27 | €14,254 | €14,082 | -€172 | -1.2% |
| Furniture and vehicles | 24 | €14,254 | €14,082 | -€172 | -1.2% |
| Current assets | 29/58 | €7,522 | €8,654 | +€1,131 | +15.0% |
| Amounts receivable within one year | 40/41 | €4,786 | €2,670 | -€2,116 | -44.2% |
| Trade receivables | 40 | €4,786 | €2,670 | -€2,116 | -44.2% |
| Cash at bank and in hand | 54/58 | €2,736 | €5,984 | +€3,247 | +119% |
| Total equity and liabilities | 10/49 | €21,776 | €22,735 | +€959 | +4.4% |
| Equity | 10/15 | €1,482 | €590 | -€892 | -60.2% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€518 | -€1,410 | -€892 | -172% |
| Amounts payable | 17/49 | €20,294 | €22,145 | +€1,851 | +9.1% |
| Amounts payable within one year | 42/48 | €20,294 | €22,145 | +€1,851 | +9.1% |
| Trade debts | 44 | €2,370 | €4,547 | +€2,177 | +91.8% |
| Suppliers | 440/4 | €2,370 | €4,547 | +€2,177 | +91.8% |
| Taxes, remuneration and social security | 45 | €2,264 | €1,325 | -€938 | -41.4% |
| Taxes | 450/3 | €2,264 | €1,325 | -€938 | -41.4% |
| Other amounts payable | 47/48 | €15,660 | €16,272 | +€612 | +3.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,496 | €3,922 | +€1,425 | +57.1% |
| Other operating charges | 640/8 | €395 | - | -€395 | |
| Gross operating margin | 9900 | €2,408 | €3,105 | +€696 | +28.9% |
| Operating profit (loss) | 9901 | -€483 | -€817 | -€334 | -69.2% |
| Financial charges | 65/66B | €35 | €74 | +€39 | +112% |
| Recurring financial charges | 65 | €35 | €74 | +€39 | +112% |
| Profit (loss) for the period before taxes | 9903 | -€518 | -€892 | -€373 | -72.1% |
| Profit (loss) for the period | 9904 | -€518 | -€892 | -€373 | -72.1% |
| Profit (loss) for the period to be appropriated | 9905 | -€518 | -€892 | -€373 | -72.1% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.